Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development servicesSyngene International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster. The investments included a dedicated, state-of-the-art